Hakeem A, Shah JA, Kumar R, Ali A, et al. Twice-Daily Clopidogrel vs Ticagrelor to Reduce Short-Term Major Adverse Cardiovascular Events After Primary Percutaneous Coronary Intervention: The TADCLOT Trial. J Am Coll Cardiol 2025;86:2330-2345.
PMID: 40892606